因?yàn)?/c>缺乏足夠的病毒培養(yǎng)體系而被迫停止不能進(jìn)行下去。
The future seems to hold great promise for HCV specific oral drugs that will be more effective and better tolerated.
未來似乎有望產(chǎn)生更有效更耐受的針對丙肝病毒的口服藥物。
The rate of spontaneous clearance of childhood HCV infection was comparable between transfusional and nontransfusional cases.
在輸血引起的和非輸血引起的病例中，兒童HCV感染的自發(fā)清除率是大致相同的。
Incorporation of these molecular markers could help to improve organ allocation for HCV-HCC patients.
聯(lián)合這些分子標(biāo)志物能幫助提高器官在HCV-肝細(xì)胞癌患者中的分配。
The lack of an in vitro viral replication system and the small animal model of HCV infection hampers anti-HCV studies and drug screening.
由于尚未建立HCV體外復(fù)制模型和小動物感染模型，限制了抗HCV作用研究和藥物篩選工作。
Due to above complications, co-infection with HCV and HIV-1 has imposed a critical challenge in the management of these patients.
綜上所述，HIV和HCV的共感染為我們治療這類病人提出了一個巨大的挑戰(zhàn)。
To investigate further, the researchers studied 1051 HCV patients and found that 35% carried at least one HFE gene mutation.
更進(jìn)一步，研究者研究了1051名HCV病人并發(fā)現(xiàn)35%攜帶有至少一種HFE基因突變。
Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
肝炎病毒（HCV）：作為一種輔助治療，以加快在藥物療法的護(hù)理標(biāo)準(zhǔn)首先病毒載量下降。
The results indicated that hepatitis C might be still spreading in the HCV-endemic area now.
本研究的結(jié)果顯示目前C型肝炎仍在梓官鄉(xiāng)傳播中。
Hepatitis C virus (HCV) is a major factor of non-A non-B hepatitis transmitted mainly through blood products and is a global health problem.
丙型肝炎病毒（HCV）是輸血后肝炎的主要致病因子，給人類的健康造成了極大的危害。
Liver tropic virus (HCV, HBV) to increase liver damage, especially in the case of infection overlap.
嗜肝病毒感染（HCV、HBV）加重肝臟損傷，尤以重疊感染為甚。
This culture system provides a breakthrough in studying HCV replication in non transformed hepatocytes, the natural target of the virus.
該病毒培養(yǎng)系統(tǒng)是非突變肝細(xì)胞內(nèi)HCV復(fù)制擴(kuò)增技術(shù)的突破。
Prof Robert Thimme: For HCV patients we have two distinct populations which are either co expressing the inhibitor receptor or not.
Thimme教授：丙型肝炎患者存在兩種不同的人群，一種共表達(dá)抑制性受體，另一種不表達(dá)。
The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.
本發(fā)明也涉及用于對患者治療或預(yù)防HCV感染的藥盒或藥包。
Our study further explores the potential effect these flavonoids have in preventing HCV reinfection following liver transplantation.
我們的研究是要進(jìn)一步探索這些黃酮類化合物在預(yù)防移植后肝臟再次感染HCV的潛在作用。
Interestingly, HCV replication in the T cells was prevented after neutralization of the virus, and by treatment with interferon.
有趣的是，丙型肝炎病毒在T細(xì)胞中的復(fù)制能被干擾素抑制。
Therefore, therapeutic modulation of insulin sensitivity in patients with HCV infection may have clinical relevance.
因此，對HCV感染患者進(jìn)行胰島素敏感性的治療性調(diào)整可能會有臨床意義。
Question 1: For those reasons, had you come to my STD clinic, we would not have tested you for HBV or HCV, even if you requested it.
問題1：由于這些理由，你來咨詢你的性病，我們就不會把你當(dāng)成乙肝或丙肝測試，即使你請求了它。
Hepatitis C virus (HCV) infection is the most common chronic blood-borne viral infection in the United States.
丙型肝炎病毒（HCV）感染是最常見的慢性血源性病毒在美國感染。
Intravenous injection to HCV, HBV infection than single or overlapping iron absorption increased significantly.
靜脈注射者HCV、HBV單項(xiàng)或重疊感染較燙吸明顯增高。
HCV recombinant immunoblot assay (RIBA) and HCV RNA testing are used to confirm the diagnosis of HCV infection.
使用丙肝病毒重組免疫印跡分析技術(shù)和丙肝病毒核糖核酸檢測對丙肝病毒感染進(jìn)行確診。
Pathogenesis of HCV-associated MPGN is mediated by glomerular deposition of circulating immune complexes containing HCV and anti-HCV.
丙型肝炎發(fā)病機(jī)制的相關(guān)系膜增生型腎炎是介導(dǎo)的腎小球沉積的循環(huán)免疫復(fù)合物含有丙型肝炎病毒和抗-HCV。
While HCV is generally considered to be a curable disease, for many persons this is not a reality.
雖然一般認(rèn)為丙肝是可以治愈的，但很多人卻未能治愈。
Although the genotype-1 variant is the most common HCV strain in the United States, other genotypes prevail across Europe, Asia, and Africa.
盡管基因型-1變異是最常見的C型肝炎病毒在美國的壓力，其他基因型盛行在歐洲，亞洲和非洲。
Hepatology Digest: Both host and viral factors are involved in chronic HCV infection, and escape from innate and adaptive immune responses.
《國際肝病》：宿主和病毒因素都參與了慢性HCV感染以及固有和適應(yīng)性免疫應(yīng)答逃避。
There is another protein with a different open reading frame from core protein within the HCV C gene.
除了核蛋白外，在丙型肝炎病毒核基因內(nèi)，尚有一蛋白產(chǎn)生。
abstract: BACKGROUND: Safety of kidney transplantation in hepatitis C virus (HCV)-positive patients has been paid increasing attention.
背景：對于丙肝病毒陽性患者接受腎移植后安全性的問題是目前大家關(guān)注的熱點(diǎn)。
HCV is generally considered to be a curable disease but for many persons this is not a reality.
一般情況下，丙肝病毒被認(rèn)為是可治愈的疾病，然而，對許多人而言，事實(shí)卻并非如此。
We used an antibody-virus interaction assay to analyze the interaction of the antisera and HCV viral particles in vitro.
最后通過研究抗體和病毒間的相互作用分析基因免疫誘導(dǎo)產(chǎn)生的抗血清在體外與HCV的相互作用情況。
Objective To investigate the possibility and risk factors of intrauterine transmission of hepatitis virus C(HCV) in Taiyuan City.
目的了解丙型肝炎病毒是否（HCV）宮內(nèi)傳播狀況及其危險因素。
HCV is usually spread when blood from a person infected with HCV enters the body of someone who is not infected.
當(dāng)受丙肝病毒感染者的血液進(jìn)入未受感染者的身體時發(fā)生丙肝病毒傳播。
Finally, virus particles were examined by electron microscopy and shown to possess the expected size and shape of HCV virus particles.
最終，電鏡觀察到病毒顆粒形態(tài)結(jié)構(gòu)均達(dá)到預(yù)想狀態(tài)。
英 
